TargetKappa-type opioid receptor(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataKi: 210nMAssay Description:Binding affinity towards human kappa opioid receptorMore data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataKi: 483nMAssay Description:Binding affinity towards human adenosine A3 receptorMore data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataKi: 6.82E+3nMAssay Description:Binding affinity towards human adenosine A3 receptorMore data for this Ligand-Target Pair
TargetAdenosine receptor A3(Mus musculus)
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity towards mouse adenosine A3 receptorMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataIC50: 440nMAssay Description:Inhibition of human ABCG2 in human R5 cells assessed as inhibition of mitoxantrone efflux measured by flow cytometric analysisMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:Inhibition of human ABCG2 in human R5 cells assessed as inhibition of mitoxantrone efflux measured by flow cytometric analysisMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataIC50: 2.57E+3nMAssay Description:Inhibition of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataIC50: 2.59E+3nMAssay Description:Inhibition of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataIC50: 4.01E+3nMAssay Description:Inhibition of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataIC50: 4.98E+3nMAssay Description:Inhibition of human ABCG2 in human R5 cells assessed as inhibition of mitoxantrone efflux measured by flow cytometric analysisMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 24nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 13nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 13nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 50nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 1.42E+3nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 70nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 14nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 13nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 80nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair
TargetBroad substrate specificity ATP-binding cassette transporter ABCG2(Homo sapiens (Human))
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
National Cancer Institute (Ba, Mm, Sl, Sva)
Curated by ChEMBL
Affinity DataEC50: 16nMAssay Description:Activation of human ABCG2-mediated ATPase activity preincubated for 2 mins followed by ATP addition and measured after 20 mins by colorimetric assayMore data for this Ligand-Target Pair